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Background: Tobacco will soon be the biggest cause of death worldwide, with the greatest burden being
borne by low and middle-income countries where 8/10 smokers now live.
Objective: This study aimed to quantify the direct burden of smoking for cardiovascular diseases (CVD) by
calculating the population attributable fractions (PAF) for fatal ischaemic heart disease (IHD) and stroke
(haemorrhagic and ischaemic) for all 38 countries in the World Health Organization Western Pacific and
South East Asian regions.
Design and subjects: Sex-specific prevalence of smoking was obtained from existing data. Estimates of the
hazard ratio (HR) for IHD and stroke with smoking as an independent risk factor were obtained from the
,600 000 adult subjects in the Asia Pacific Cohort Studies Collaboration (APCSC). HR estimates and
prevalence were then used to calculate sex-specific PAF for IHD and stroke by country.
Results: The prevalence of smoking in the 33 countries, for which relevant data could be obtained, ranged
from 28–82% in males and from 1–65% in females. The fraction of IHD attributable to smoking ranged
from 13–33% in males and from ,1–28% in females. The percentage of haemorrhagic stroke attributable
to smoking ranged from 4–12% in males and from ,1–9% in females. Corresponding figures for
ischaemic stroke were 11–27% in males and ,1–22% in females.
Conclusions: Up to 30% of some cardiovascular fatalities can be attributed to smoking. This is likely an
underestimate of the current burden of smoking on CVD, given that the smoking epidemic has developed
further since many of the studies were conducted.
W
orldwide, the only two major causes of death whose
effects are increasing rapidly are HIV and tobacco
use.1 By 2030, tobacco is expected to be the single
biggest cause of death worldwide, accounting for about 10
million deaths per year, more than the total number of deaths
from malaria, maternal and major childhood conditions, and
tuberculosis combined. This burden will be borne largely by
low and middle-income countries (LMIC) where eight out of
10 smokers now live.1 It will further increase disparities in
health and wealth in LMIC, as smoking is known to be
increasing in poorer countries and even more so in poorer
people in poor countries.2 3
The current high prevalence of smoking and its upward
trend foreshadow challenges in the future, not only for
population health and health care, but also economically. In
LMIC, high tobacco use exerts well known direct effects in
terms of increased morbidity and mortality from cardiovas-
cular diseases (CVD), respiratory diseases and cancer, and
also indirect health effects due to the decreased ability of a
household to spend money on health care, education and
healthy foods because of money spent on tobacco.4 Outside of
the household, the indirect health effects of tobacco are felt
in reduced productivity by removing people from the work-
force.2 For example, of the expected nine million deaths from
CVD in China in 2030, over half will occur in the prime
working ages 35–64.5
In conjunction with rising the prevalence of smoking,
many LMIC are in, or entering, what has been termed the
epidemiologic transition and are experiencing an increase in
CVD and other non-communicable diseases.6 This has been
well documented by the World Bank’s Global Burden of
Disease project, and by the World Health Organization
MONICA (Monitoring Trends and Determinants in
Cardiovascular Disease) project.6 7 These demonstrate that
LMIC currently contribute 80% of global CVD-related deaths
and 87% of CVD-related disability.6 Notably, of all the
countries included in the MONICA project, China (Beijing)
demonstrated the greatest recent increase in heart disease.7
The impact of this increase cannot be understated in the
Asia-Pacific region, estimated to contain at least 65% of the
world’s population.8 Of all the major and modifiable risk
factors for CVD (smoking, hypertension, diabetes, hyperlipi-
daemia, and lack of exercise), tobacco smoking is almost
certainly the most important in LMIC due to its high
prevalence as well as its unarguable negative impacts on
health.
To the best of our knowledge, there are no published
studies of the population attributable fraction of CVD caused
by smoking in the Western Pacific or South East Asian
regions. However, there have been studies of the overall risk
of dying due to smoking in these regions. For instance, a
large retrospective study in China, the world’s largest
producer and consumer of tobacco, revealed that one smoker
in four in that country has already been killed by tobacco.9
Another study from Hong Kong estimates that about 33% of
all male deaths and about 5% of all female deaths are caused
by smoking.10 The proportion of all deaths caused by smoking
Abbreviations: APCSC, Asia Pacific Cohort Studies Collaboration;
CVD, cardiovascular disease; IHD, ischaemic heart disease; LMIC, low
and middle-income countries; PAF, population attributable fractions; HR,
hazard ratio; WHO, World Health Organization
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in the region is still currently lower than in ‘‘the West’’,
mainly because the full effects of the large recent increases in
male smoking are not yet evident.11 Yet, even at this early
stage, because of the size of its population, China has more
deaths from tobacco than the United States or Russia.11
Trends
Whereas current mortality from past smoking patterns can
serve as an early warning, greater concern should be directed
toward the much larger number of deaths that are expected
in coming decades as a result of current smoking, especially
for LMIC. Unfortunately, knowing what to expect is difficult
as detailed age- and sex-specific trends in smoking by
country in the WHO Western Pacific and South East Asian
regions are not consistently available. However, it is known
that overall tobacco consumption increased in all LMIC in the
past two decades by about 3.4% per year, compared with
declines in consumption in high-income countries.5 In
selected countries in the Western Pacific and South East
Asian regions, percentage increases in per capita cigarette
consumption over the period 1970–1990 range from 30% for
Thailand and Cambodia to more than 130% for Nepal, China
and Indonesia.5 For example, the average consumption of
cigarettes per Chinese man per day was 1 in 1952, 4 in 1972,
10 in 1992, and 11 in 1996.5 Cases of CVD are increasing
simultaneously, with anticipated increases of 120% for
women and 137% for men in LMIC between 1990 and
2020, compared with age-related increases of between 30–
60% in high-income countries.2 These are conservative
estimates, as they do not take into account the likely increase
in the prevalence of other CVD risk factors over time.
Rationale
This paper addresses a major area of uncertainty, as indicated
by the World Bank Report on Smoking, the lack of knowl-
edge regarding the burden of tobacco-attributable disease, as
well as estimates for the prevalence and impact of smoking
on women in LMIC.5 It quantifies the direct burden of
smoking for cardiovascular diseases (CVD) by calculating the
population attributable fractions (PAFs) for ischaemic heart
disease (IHD) and stroke (haemorrhagic and ischaemic) for
countries in the WHO Western Pacific and South-East Asian
regions. The PAF provides estimates of the proportion of
heart disease and stroke cases in a country that could be
avoided if smoking were eliminated.
METHODS AND POPULATIONS
Calculation of the PAFs required estimates of the prevalence
of smoking by country, as well as estimates of hazard ratio
(HR) for CVD associated with smoking.
Prevalence of smoking
Data on the prevalence of smoking for adult males and
females were obtained for countries in the WHO Western
Pacific and South-East Asian regions. Although the WHO
does not recognise them as separate countries, Hong Kong,
Macau and Taiwan were considered separately from China
because these regions have unique health, political and
administrative bodies that may influence the prevalence of
smoking. Data on prevalence were obtained from studies
compiled by the WHO and supplemented by data from
national surveys, available either through Medline or via
national government or non-governmental organisation
websites. These other surveys were used only if they provided
more recent data or where the WHO did not have sex-specific
data on smoking for a particular country. Only those studies
compiled by the WHO and judged by the WHO to be
‘‘methodologically sound and to provide reasonable reliable
and comparable results’’, or those national surveys that used
random sampling techniques to obtain representative popu-
lation estimates from countries in the WHO Western Pacific
and South-East Asian regions, were used to obtain estimates
of the prevalence of smoking.9
Relative risk of cardiovascular disease
Age-adjusted estimates of the relative risk of smoking for
cardiovascular death were obtained from the Asia Pacific
Cohort Studies Collaboration (APCSC). The APCSC is an
overview of cohort studies in the region. Details on the
APCSC, including study identification, data collection, and
event verification are described elsewhere.12 All studies
included in APCSC were conducted prospectively in popula-
tions from the Asia-Pacific region, had at least 5000 person
years of follow-up and recorded age, sex, and blood pressure
at baseline and vital status at the end of the follow-up.
Studies were excluded from the APCSC if entry was
dependent upon the individual having a particular condition
or risk factor.
All data on current cigarette smoking (yes/no) were self-
reported at enrolment. Cardiovascular deaths were ascer-
tained using monitoring, re-surveying and/or record linkage,
and classified according to the ninth revision of the
International Classification of Diseases (ICD): IHD (ICD 410–
414); stroke (430–438); haemorrhagic stroke (431.0–432.9);
ischaemic stroke (433.0–434.9). Deaths were ascribed solely
to their underlying cause. Analyses used individual partici-
pant data, and were restricted to individuals aged 20 years
and over at the time of the baseline survey for whom
smoking status was recorded.
Population attributable fraction
Using the estimates of prevalence obtained from the
literature and the HR from APCSC, population attributable
fractions (%) for fatal ischaemic heart disease, haemorrhagic
and ischaemic stroke caused by smoking were calculated for
each country, for both males and females, using the formula:
PAF = [100 6 prevalence 6 (HR21)]/[100 + prevalence 6
(HR21)], where prevalence is in %.
RESULTS
Nationally representative data on the sex-specific prevalence
of smoking were available for all 27 countries in the WHO
Western Pacific Region except for the Marshall Islands and
the Solomon Islands; and for all 11 countries in the WHO
South-East Asia Region except for Bhutan, North Korea and
Timor-Leste. Also, no data were available for Macau. For the
Solomon Islands and Timor-Leste, data were available only
for female smoking prevalence, 33% and 1.1%, respectively,
and the total prevalence of smoking (males and females) in
Bhutan is reported to be 1%.13–15 The prevalence of smoking in
the other 33 countries in the WHO Western Pacific and
South-East Asian regions (plus Hong Kong and Taiwan)
ranged from 28–82% in males and from 1–65% in females
(fig 1).
A previous individual participant data analysis of the 40
cohort studies from APCSC provided estimates of HR for
CVD.16 In APCSC there are no significant differences
(p . 0.05) in the relative effect of smoking on IHD or stroke
between countries, between Asia and Australia/New Zealand
(ANZ) or between women and men. The HRs (95%
confidence intervals (CI)) comparing current smokers with
non-smokers are: 1.60 (95% CI 1.49 to 1.72) for ischaemic
heart disease; 1.19 (95% CI 1.06 to 1.33) for haemorrhagic
stroke; and 1.38 (95% CI 1.24 to 1.54) for ischaemic stroke.
Figures 2–4 present the population attributable fractions
for males and females for IHD, haemorrhagic and ischaemic
stroke caused by smoking for each country in the WHO
Western Pacific and South-East Asian regions. Countries are
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ranked by the total prevalence of smoking in fig 1 and this
ranking remains for figs 2–4. The fraction of IHD attributable
to smoking ranged from 13–33% in males and from ,1–28%
in females (fig 2). The fraction of haemorrhagic stroke
attributable to smoking ranged from 4–12% in males and
from ,1–9% in females (fig 3). The fraction of ischaemic
stroke attributable to smoking ranged from 11–27% in males
and from ,1–22% in females (fig 4).
DISCUSSION
We have quantified the direct burden of smoking on
cardiovascular diseases (CVD) in the WHO Western Pacific
and South East Asian regions by calculating the PAFs for IHD
and stroke. Results from this study suggest that up to ,30%
of fatal CVD in these populations can be attributed to
smoking, depending on the outcome of interest. Much of the
projected increase in mortality over the next 50 years could be
avoided if adults quit smoking; however, quitting remains
rare in LMIC.5
Interestingly, this study demonstrated that Australia and
New Zealand, the two higher-income countries in the WHO
Western Pacific and South-East Asian regions, with
predominantly white populations, have relatively low
smoking prevalence and therefore low PAFs for CVD. As
expected, the attributable fractions for all outcomes are
greater for males because their prevalence of smoking is
currently higher. PAFs for CVD in women will almost
certainly increase in the future because smoking by women
Sri Lanka (2001)21
Singapore (2001)22
Hong Kong (2000)23
Palau (1997)24
India (1999)25
Australia (2004)26
Thailand (2001)27
Micronesia (1994)28
New Zealand (1998)29
Taiwan (1999)30
Maldives (2001)31
Fiji (1997)32
Malaysia (1996)33
Brunei darussalam (1979)34
Vietnam (1998)35
Lao (1995)36
Cook Island (1987)37
Philippines (2001)38
Japan (2000)39
Vanuatu (1990)40
Nepal (2000)41
Myanmar (2001)42
China (1996)43
Bangladesh (2001)44
South Korea (1995)45
Indonesia (2001)56
Mongolia (1999)47
Tonga (1991)48
Cambodia (1999)49
Tuvalu (1981)50
Samoa (1995)51
Niue (1987)37
Nauru (1987)37
Kiribati (1987)37
Papua New Guinea (1990)52
1006020 40040 20
Prevalence (%)
Female
76 80
82 65
61 47
63 21
58 24
51 31
67 10
62 14
55 19
69 3
68 3
48 21
63 4
43 22
40 24
50 10
47 12
51 8
40 17
41 15
51 4
40 14
49 4
36 16
37 15
47 5
26 24
42 0.6
39 2
19 16
29 3
22 8
25 4
24 4
26 2
Male
60100 8080
Figure 1 Prevalence of smoking in the
Western Pacific and South East Asian
Regions by sex.21–52
Fraction of CVD due to smoking 183
www.tobaccocontrol.com
 group.bmj.com on June 23, 2014 - Published by tobaccocontrol.bmj.comDownloaded from 
in LMIC in these regions is expected to increase in the coming
years.2 The attributable fractions for CVD for Australia and
New Zealand from this study are similar to estimates
previously published by Peto et al in their monograph
providing PAFs for various outcomes caused by smoking in
developed countries.17 However, the methods used here are
more direct and robust.
While this paper addresses only the PAF for heart disease
and stroke associated with smoking, not only is the
prevalence of smoking increasing in the Western Pacific
and South East Asian regions, but the countries in these
regions are also experiencing increases in other risk factors
for CVD, including overweight/obesity, diabetes, hyperten-
sion and dyslipidaemia.18 Ominously, these trends are likely
to work together, further amplifying observed death and
disability from IHD and stroke.
Strengths and limitations
This study has the strength of being able to calculate PAFs
using HRs from the region based on the largest-ever study of
CVD in the Asia-Pacific, and one of the largest anywhere in the
world. The size of the APCSC means that the overall estimates
of the relative effects of smoking are more precise than those
employed in most previous calculations and offer an improve-
ment over previous indirect methods for estimation.
However, the APCSC does have a number of disadvantages,
particularly with respect to the assessment of smoking.
First, this study needed to define smoking as a simple
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self-reported, dichotomous variable (yes/no) reflecting status
at baseline, since few variables on smoking habits are
included in the Collaboration. Thus PAFs could not be
calculated using duration of smoking, although duration is
recognised as more important than daily consumption of
cigarettes in determining the effects of smoking on some
health outcomes such as cancer.16 However, the relative
importance of duration versus daily consumption smoking
measures is less clear for cardiovascular outcomes.19 If the
measurement of the duration of smoking is important for
CVD, as it is for cancer, then the inclusion of ex-smokers in
the reference group will have led to an underestimation of
the RRs associated with current versus never smoking and a
concomitant underestimation of PAFs.
A second limitation is that no objective measures of
smoking status were available in the APCSC database, nor in
studies used to estimate the prevalence of smoking. Any
misclassification of current smokers as former or never-
smokers will have served to underestimate the HRs and
hence the PAFs.
A third limitation is that, although there were no
statistically significant differences in APCSC between coun-
tries in HR, for IHD or stroke, the same measure of HR has
been used to calculate the PAFs for countries not represented
in APCSC (for example, India). A fourth limitation is that
although the estimates of risk were adjusted for age, data on
prevalence of smoking were not. A final limitation is that the
individual studies included in the APCSC used different
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methods to verify CVD outcomes, and the lack of standardi-
sation could have some effect on the estimation of the HR. Of
particular importance for the current study is that only 57%
of fatal strokes were classified by subtype and, while
pathological diagnoses were verified by imaging or autopsy,
limited information was available from many studies.
In summary, all of the limitations in this study are likely to
have resulted in conservative estimates of the PAFs. This only
further underscores the impact of smoking on CVD in these
regions.
Future
CVD and its risk factors are moving not only from high-
income to LMIC, but also from the more affluent in LMIC to
the less affluent. Yet, a recent assessment by the WHO has
indicated that the capacity of many countries to prevent and
treat chronic diseases remains extremely weak.2 There is a
need to develop integrated approaches to prevention,
surveillance and control of chronic diseases. There is also a
need to continue monitoring the state of smoking and CVD in
order to ensure country-specific policies and programmes for
the prevention and treatment of CVD are appropriate, and to
gauge the effectiveness of current interventions. The present
study is a useful step, and future studies with country-
specific HRs are warranted.
Conclusion
There is convincing evidence that, even on conservative
assumptions, tackling smoking could prevent millions of
deaths over the next few decades. A decrease in the
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prevalence of smoking would not only address the increasing
rates of CVDs and their risk factors but will also contribute
substantially to reducing the incidence and impact of other
chronic diseases, such as cancer and chronic respiratory
diseases, that share smoking as a common risk factor. There
are existing tobacco control policies that have been shown to
be effective.20 Implementation of the Framework Convention
on Tobacco Control and following through with its protocols
is likely the best first step toward addressing the large
fraction of cardiovascular disease that is attributable to
smoking.
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